Clinical Trial

Evaluation of the Phantom X Implantable EMG Sensor System for Myoelectric Prosthesis Control

Study acronym: CYBORG
Recruiting
View on ClinicalTrials.gov →
Summary
The CYBORG Study is a first-in-human clinical investigation evaluating the safety and performance of the Phantom X System, an implantable electromyography (EMG) sensor array designed to provide control of upper-limb prostheses. The study will assess surgical feasibility, device function, signal quality, and the system's ability to support intuitive prosthetic control during functional tasks. Participants will undergo implantation of the Phantom X sensors and complete a series of in-clinic visits to assess functional performance of the Phantom X system. Patient-reported outcomes will also be collected at various timepoints.
Protocol Amendment History 1 change
critical Recruitment opened 2026-06-25
Trial Details
NCT Number NCT07325708
Lead Sponsor Phantom Neuro Inc.
Collaborators: Cabrini Health, Melbourne, Australia, ProMotion Prosthetics, Moorabbin, Australia
Conditions Upper Limb Amputation Below Elbow (Injury), Wrist Disarticulation, Transradial Amputation
Enrollment 10 participants
Start Date 2026-04-17
Primary Completion 2026-12 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2026-06-24